Research programme: PPAR modulators - AbGenomicsAlternative Names: AbGn-L; AbGn-X
Latest Information Update: 17 Jun 2011
At a glance
- Originator AbGenomics Corporation
- Mechanism of Action Peroxisome proliferator-activated receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Metabolic disorders; Type 2 diabetes mellitus
Most Recent Events
- 04 Aug 2005 Preclinical trials in Type-2 diabetes mellitus in Taiwan (unspecified route)
- 04 Aug 2005 Preclinical trials in Metabolic disorders in Taiwan (unspecified route)